Explore our Cymbiotika collection to find the right products for you!
Understanding the differences between these treatments helps patients and clinicians make informed decisions about diabetes management, particularly when first-line therapies such as metformin prove insufficient
Synergy with HRT : They combine effectively with hormone therapy for compounded benefits.[4-6] However, alternatives exist for those seeking different approaches
There are a variety of needle lengths and gauges to choose from, depending on the injection site and individual preferences
Dispersive pipette extraction and HPLC-DAD for the determination of polyphenols in grape juice
Specifically, NICE suggests considering a DPP-4 inhibitor as a second agent when: The patient has a high risk of hypoglycaemia (making sulfonylureas less suitable) Weight management is a concern and a sulfonylurea's weight-gaining effects are undesirable An SGLT-2 inhibitor is contraindicated or not tolerated NICE NG28 recommends that in patients with established atherosclerotic cardiovascular disease, heart failure, or chronic kidney disease, an SGLT-2 inhibitor should generally be prioritised often alongside or instead of metformin due to its organ-protective benefits